These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33819447)

  • 1. Neurodegeneration: Impact of S-nitrosylated Parkin, DJ-1 and PINK1 on the pathogenesis of Parkinson's disease.
    Sircar E; Rai SR; Wilson MA; Schlossmacher MG; Sengupta R
    Arch Biochem Biophys; 2021 Jun; 704():108869. PubMed ID: 33819447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
    Dodson MW; Guo M
    Curr Opin Neurobiol; 2007 Jun; 17(3):331-7. PubMed ID: 17499497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Variants in the Parkin, PINK1, and DJ-1 Genes along with Evidence for their Pathogenicity.
    Hauser DN; Primiani CT; Cookson MR
    Curr Protein Pept Sci; 2017; 18(7):702-714. PubMed ID: 26965687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1.
    van der Merwe C; Jalali Sefid Dashti Z; Christoffels A; Loos B; Bardien S
    Eur J Neurosci; 2015 May; 41(9):1113-25. PubMed ID: 25761903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkin and PINK1 functions in oxidative stress and neurodegeneration.
    Barodia SK; Creed RB; Goldberg MS
    Brain Res Bull; 2017 Jul; 133():51-59. PubMed ID: 28017782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DJ-1 is indispensable for the S-nitrosylation of Parkin, which maintains function of mitochondria.
    Ozawa K; Tsumoto H; Miura Y; Yamaguchi J; Iguchi-Ariga SMM; Sakuma T; Yamamoto T; Uchiyama Y
    Sci Rep; 2020 Mar; 10(1):4377. PubMed ID: 32152416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat Striatum.
    Creed RB; Menalled L; Casey B; Dave KD; Janssens HB; Veinbergs I; van der Hart M; Rassoulpour A; Goldberg MS
    Neuroscience; 2019 Jun; 409():169-179. PubMed ID: 31029729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson's Disease Models.
    Oh CK; Sultan A; Platzer J; Dolatabadi N; Soldner F; McClatchy DB; Diedrich JK; Yates JR; Ambasudhan R; Nakamura T; Jaenisch R; Lipton SA
    Cell Rep; 2017 Nov; 21(8):2171-2182. PubMed ID: 29166608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress.
    Moore DJ; Zhang L; Troncoso J; Lee MK; Hattori N; Mizuno Y; Dawson TM; Dawson VL
    Hum Mol Genet; 2005 Jan; 14(1):71-84. PubMed ID: 15525661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hexokinases link DJ-1 to the PINK1/parkin pathway.
    Hauser DN; Mamais A; Conti MM; Primiani CT; Kumaran R; Dillman AA; Langston RG; Beilina A; Garcia JH; Diaz-Ruiz A; Bernier M; Fiesel FC; Hou X; Springer W; Li Y; de Cabo R; Cookson MR
    Mol Neurodegener; 2017 Sep; 12(1):70. PubMed ID: 28962651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
    Hennis MR; Marvin MA; Taylor CM; Goldberg MS
    Neurobiol Dis; 2014 Feb; 62():113-23. PubMed ID: 24075852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson's disease.
    Sunico CR; Nakamura T; Rockenstein E; Mante M; Adame A; Chan SF; Newmeyer TF; Masliah E; Nakanishi N; Lipton SA
    Mol Neurodegener; 2013 Aug; 8():29. PubMed ID: 23985028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement and interplay of Parkin, PINK1, and DJ1 in neurodegenerative and neuroinflammatory disorders.
    Wilhelmus MM; Nijland PG; Drukarch B; de Vries HE; van Horssen J
    Free Radic Biol Med; 2012 Aug; 53(4):983-92. PubMed ID: 22687462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated Interorganellar Crosstalk of Mitochondria in the Pathogenesis of Parkinson's Disease.
    Sironi L; Restelli LM; Tolnay M; Neutzner A; Frank S
    Cells; 2020 Jan; 9(1):. PubMed ID: 31963435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkin, PINK1 and DJ1 as possible modulators of mTOR pathway in ganglioglioma.
    Drapalo K; Jozwiak J
    Int J Neurosci; 2018 Feb; 128(2):167-174. PubMed ID: 28803490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular insights into Parkinson's disease.
    Rochet JC; Hay BA; Guo M
    Prog Mol Biol Transl Sci; 2012; 107():125-88. PubMed ID: 22482450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
    Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exon dosage variations in Brazilian patients with Parkinson's disease: analysis of SNCA, PARKIN, PINK1 and DJ-1 genes.
    Moura KC; Junior MC; de Rosso AL; Nicaretta DH; Pereira JS; José Silva D; Santos-Rebouças CB; Pimentel MM
    Dis Markers; 2012; 32(3):173-8. PubMed ID: 22377733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parkin and mitochondria].
    Mitsui T; Kuroda Y; Kaji R
    Brain Nerve; 2008 Aug; 60(8):923-9. PubMed ID: 18717196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.